Target intelligence / Profile preview

DNA or RNA (within cancer cell) (null)

Target
null
Molecular classification
Nucleic acid (DNA, RNA), Genome (for DNA), Transcriptome (for all RNA species), Other (as foundational molecular components)
01

Overview

DNA and RNA within cancer cells represent the fundamental molecules encoding, transmitting, and regulating all genetic information[2][4][5]. DNA (deoxyribonucleic acid) stores the cell's hereditary information, while RNA (ribonucleic acid) transcribes and transmits the DNA code for the synthesis of proteins or regulatory functions[2][3][6]. Mutations or epigenetic dysregulation of DNA and RNA contribute critically to cancer development, driving aberrant cell proliferation, evasion of apoptosis, and therapeutic resistance[4][7]. Modern cancer therapies target specific DNA mutations, gene fusions, epigenetic modifications, or RNA transcripts, either directly (e.g., antisense oligonucleotides, siRNA) or by using drugs that damage or modify DNA/RNA and their associated regulatory proteins[1][3][6]. Given their ubiquity and centrality, "DNA/RNA within cancer cell" is not a single therapeutic target, but alterations in DNA and RNA provide both disease causality and actionable avenues for diagnostics and drug development.

Other names
genetic materialnucleic acidsgenome (for DNA)transcriptome (for RNA)chromatin (for DNA in complex with proteins)
02

Mechanism of action

Induce DNA damage leading to apoptosis\nInhibit DNA or RNA synthesis\nModify gene expression by targeting epigenetic marks\nSilence or degrade specific RNA transcripts\nModulate splicing or translation of mRNAs

03

Biological functions

Genetic information storage (DNA)Transcription (DNA to RNA)Translation (RNA to protein)Gene regulation (including via non-coding RNA)Cell cycle controlCell proliferationApoptosisCancer initiation and progression
04

Disease associations

CancerOther (mutations or abnormal expression also contribute to other diseases)
05

Safety considerations

Off-target effects (genotoxicity risking harm to normal cells)Mutagenesis and secondary malignancies with DNA-targeted drugsToxicity due to inhibition of replication/transcription in normal cellsRNA-targeted therapies may have immune activation or unpredictable effects
06

Interacting drugs

DNA-damaging agents (e.g., cisplatin, doxorubicin)

4 more in the full profile.

07

Biomarkers

Specific gene mutations (e.g., BRCA1, KRAS, EGFR)Gene expression panels (e.g., mRNA expression signatures)Non-coding RNA levels (e.g., miRNA profiles)Chromosomal aberrations (e.g., fusion genes, copy number variations)DNA methylation status

Beyond the preview

Go deeper on DNA or RNA (within cancer cell) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DNA or RNA (within cancer cell) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call